Global Muscle Relaxant Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare

RELEASE DATE Jun 2024
REPORT ID SI4589
PAGES 272
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Type
      2. Market Attractiveness Analysis By Route of Administration
      3. Market Attractiveness Analysis By Distribution Channel
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. The incidence of musculoskeletal disorders is increasing.
    3. Restraints
      1.  Negative effects of muscle relaxants.
    4. Opportunities
      1.  Increasing prevalence of back pain.
    5. Challenges
      1. Adverse reactions related to muscle relaxants.
  6. Global Muscle Relaxant Drugs Market Analysis and Projection, By Drug Type
    1. Segment Overview
    2. Skeletal Muscle Relaxant Drugs
    3. Facial Muscle Relaxant Drugs
  7. Global Muscle Relaxant Drugs Market Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Injectable
  8. Global Muscle Relaxant Drugs Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacy
    3. Retail Pharmacy
    4. Online Pharmacy
  9. Global Muscle Relaxant Drugs Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Muscle Relaxant Drugs Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Muscle Relaxant Drugs Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Amneal Pharmaceuticals LLC
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Ipsen Biopharmaceuticals, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Merz Pharmaceuticals, LLC. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Par Pharmaceutical 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Vertical Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Mallinckrodt
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Amgen Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Nexus Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Metacel Pharmaceuticals, LLC.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Teva Pharmaceuticals USA, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.   Actelion Pharmaceuticals Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.  Sandoz International GmbH 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  2. Global Skeletal Muscle Relaxant Drugs, Muscle Relaxant Drugs Market, By Region, 2023-2033(USD Billion)
  3. Global Facial Muscle Relaxant Drugs, Muscle Relaxant Drugs Market, By Region, 2023-2033(USD Billion)
  4. Global Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  5. Global Oral, Muscle Relaxant Drugs Market, By Region, 2023-2033(USD Billion)
  6. Global Injectable, Muscle Relaxant Drugs Market, By Region, 2023-2033(USD Billion)
  7. Global Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  8. Global Hospital Pharmacy, Muscle Relaxant Drugs Market, By Region, 2023-2033(USD Billion)
  9. Global Retail Pharmacy, Muscle Relaxant Drugs Market, By Region, 2023-2033(USD Billion)
  10. Global Online Pharmacy, Muscle Relaxant Drugs Market, By Region, 2023-2033(USD Billion)
  11. North America Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  12. North America Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  13. North America Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)  
  14. U.S.  Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  15. U.S.  Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  16. U.S.  Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  17. Canada Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  18. Canada Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  19. Canada Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  20. Mexico Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  21. Mexico Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  22. Mexico Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  23. Europe Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  24. Europe Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  25. Europe Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  26. Germany Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  27. Germany Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  28. Germany Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  29. France Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  30. France Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  31. France Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  32. U.K.  Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  33. U.K.  Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  34. U.K.  Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  35. Italy Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  36. Italy Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  37. Italy Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  38. Spain Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  39. Spain Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  40. Spain Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)  
  41. Asia Pacific Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  42. Asia Pacific Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  43. Asia Pacific Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  44. Japan Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  45. Japan Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  46. Japan Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  47. China Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  48. China Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  49. China Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  50. India Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  51. India Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  52. India Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  53. South America Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  54. South America Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  55. South America Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  56. Brazil Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  57. Brazil Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  58. Brazil Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  59. The Middle East and Africa Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD   Billion)
  60. The Middle East and Africa Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD   Billion)
  61. The Middle East and Africa Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  62. UAE Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  63. UAE Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  64. UAE Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)
  65. South Africa Muscle Relaxant Drugs Market, By Drug Type, 2023-2033(USD Billion)
  66. South Africa Muscle Relaxant Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  67. South Africa Muscle Relaxant Drugs Market, By Distribution Channel, 2023-2033(USD Billion)

List of Figures 

  1. Global Muscle Relaxant Drugs Market Segmentation
  2. Muscle Relaxant Drugs Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Muscle Relaxant Drugs Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Muscle Relaxant Drugs Market
  20. Muscle Relaxant Drugs Market Segmentation, By Drug Type
  21. Muscle Relaxant Drugs Market For Skeletal Muscle Relaxant Drugs, By Region, 2023-2033 ($ Billion)
  22.  Muscle Relaxant Drugs Market For Facial Muscle Relaxant Drugs, By Region, 2023-2033 ($ Billion)
  23. Muscle Relaxant Drugs Market Segmentation, By Route of Administration
  24. Muscle Relaxant Drugs Market For Oral, By Region, 2023-2033 ($ Billion)
  25. Muscle Relaxant Drugs Market For Injectable, By Region, 2023-2033 ($ Billion)
  26. Muscle Relaxant Drugs Market Segmentation, By Distribution Channel
  27. Muscle Relaxant Drugs Market For Hospital Pharmacy, By Region, 2023-2033 ($ Billion)
  28. Muscle Relaxant Drugs Market For Retail Pharmacy, By Region, 2023-2033 ($ Billion)
  29. Muscle Relaxant Drugs Market For Online Pharmacy, By Region, 2023-2033 ($ Billion)
  30. Amneal Pharmaceuticals LLC: Net Sales, 2023-2033 ($ Billion)
  31. Amneal Pharmaceuticals LLC: Revenue Share, By Segment, 2023 (%)
  32. Amneal Pharmaceuticals LLC: Revenue Share, By Region, 2023 (%)
  33. Ipsen Biopharmaceuticals, Inc.: Net Sales, 2023-2033 ($ Billion)
  34. Ipsen Biopharmaceuticals, Inc.: Revenue Share, By Segment, 2023 (%)
  35. Ipsen Biopharmaceuticals, Inc.: Revenue Share, By Region, 2023 (%)
  36. Merz Pharmaceuticals, LLC.: Net Sales, 2023-2033 ($ Billion)
  37. Merz Pharmaceuticals, LLC.: Revenue Share, By Segment, 2023 (%)
  38. Merz Pharmaceuticals, LLC.: Revenue Share, By Region, 2023 (%)
  39. Par Pharmaceutical: Net Sales, 2023-2033 ($ Billion)
  40. Par Pharmaceutical: Revenue Share, By Segment, 2023 (%)
  41. Par Pharmaceutical: Revenue Share, By Region, 2023 (%)
  42. Vertical Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  43. Vertical Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  44. Vertical Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  45. Mallinckrodt: Net Sales, 2023-2033 ($ Billion)
  46. Mallinckrodt: Revenue Share, By Segment, 2023 (%)
  47. Mallinckrodt: Revenue Share, By Region, 2023 (%)
  48. Amgen Inc.: Net Sales, 2023-2033 ($ Billion)
  49. Amgen Inc.: Revenue Share, By Segment, 2023 (%)
  50. Amgen Inc.: Revenue Share, By Region, 2023 (%)
  51. Nexus Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  52. Nexus Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  53. Nexus Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  54. Metacel Pharmaceuticals, LLC.: Net Sales, 2023-2033 ($ Billion)
  55. Metacel Pharmaceuticals, LLC. : Revenue Share, By Segment, 2023 (%)
  56. Metacel Pharmaceuticals, LLC. : Revenue Share, By Region, 2023 (%)
  57. Teva Pharmaceuticals USA, Inc.: Net Sales, 2023-2033 ($ Billion)
  58. Teva Pharmaceuticals USA, Inc.: Revenue Share, By Segment, 2023 (%)
  59. Teva Pharmaceuticals USA, Inc.: Revenue Share, By Region, 2023 (%)
  60. Actelion Pharmaceuticals Ltd: Net Sales, 2023-2033 ($ Billion)
  61. Actelion Pharmaceuticals Ltd: Revenue Share, By Segment, 2023 (%)
  62. Actelion Pharmaceuticals Ltd: Revenue Share, By Region, 2023 (%)
  63. Sandoz International GmbH: Net Sales, 2023-2033 ($ Billion)
  64. Sandoz International GmbH: Revenue Share, By Segment, 2023 (%)
  65. Sandoz International GmbH: Revenue Share, By Region, 2023 (%)
  66. Others: Net Sales, 2023-2033 ($ Billion)
  67. Others: Revenue Share, By Segment, 2023 (%)
  68. Others: Revenue Share, By Region, 2023 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies